David D. Allison - Oct 7, 2022 Form 4 Insider Report for CinCor Pharma, Inc. (CINC)

Role
Director
Signature
/s/ Cathy Rude, Attorney-in-Fact
Stock symbol
CINC
Transactions as of
Oct 7, 2022
Transactions value $
$12,497
Form type
4
Date filed
10/12/2022, 04:28 PM
Previous filing
Jul 20, 2022
Next filing
Jan 10, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CINC Stock Option (Right to Buy) Award $12.5K +524 $23.85 524 Oct 7, 2022 Common Stock 524 $33.49 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was issued to the Reporting Person pursuant to the Issuer's Director Compensation Policy in lieu of retainer fees of $12,500.